Myria Biosciences

About:

Natural product drug discovery platform using genetically engineered cells to produce drugs.

Website: https://www.myria.bio/

Top Investors: Creator Fund

Description:

Myria have developed a genetically engineered platform that allows for the discovery of complex natural product molecules which have pharmaceutical applications. They screen tens of millions of compounds for identification and optimisation of drug lead candidates.

Total Funding Amount:

1.5M GBP

Headquarters Location:

Founded Date:

2022-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai